enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. ‘A huge shock to the system’: Doctors warn about asthma ...

    www.aol.com/huge-shock-system-doctors-warn...

    GSK did price the authorized generic lower than branded Flovent; one package of Flovent HFA in the 110 microgram dose, for example, costs $273.83, about 50% more than the $177.99 wholesale ...

  3. Parents search for Flovent alternatives as childhood asthma ...

    www.aol.com/parents-search-flovent-alternatives...

    Flovent, one of the most commonly prescribed childhood asthma inhalers, is no longer being manufactured in the United States.. This preventative medication is usually taken every day to help keep ...

  4. GSK's Blood Cancer Drug Shows Improved Survival ... - AOL

    www.aol.com/gsks-blood-cancer-drug-shows...

    On Monday, GSK plc (NYSE:GSK) announced statistically significant and clinically meaningful overall survival (OS) results from a planned interim analysis of the DREAMM-7 trial. The trial assessed ...

  5. List of GSK plc products - Wikipedia

    en.wikipedia.org/wiki/List_of_GSK_plc_products

    This is a list of products manufactured by the multinational pharmaceutical, biologics, and vaccines manufacturing company GSK. Pharmaceutical products [ edit ]

  6. ViiV Healthcare - Wikipedia

    en.wikipedia.org/wiki/ViiV_Healthcare

    The company was created as a joint venture by GSK and Pfizer in November 2009, with both companies transferring their HIV assets to the new company. [1] In 2012, Shionogi joined the company. As of December 2023, 76.5% of the company is owned by GSK, 13.5% by Pfizer and 10% by Shionogi. [ 2 ]

  7. Fluticasone furoate/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol

    In 2013, the drug was approved for use in the United States by the Food and Drug Administration (FDA) for long-term maintenance treatment of airflow obstruction in people with COPD, including chronic bronchitis and emphysema, [6] and the European Medicines Agency approved it as a second-line therapy for the treatment of COPD and asthma. [7]

  8. GSK1016790A - Wikipedia

    en.wikipedia.org/wiki/GSK1016790A

    GSK1016790A (aka GSK101) is a drug developed by GlaxoSmithKline which acts as a potent and selective agonist for the TRPV4 receptor. It has been used to study the role of TRPV4 receptors in the function of smooth muscle tissue, particularly that lining blood vessels, lymphatic system , and the bladder .

  9. GlaxoSmithKline Dives on Weak Growth - AOL

    www.aol.com/2012/04/25/glaxosmithkline-dives-on...

    LONDON -- "Big pharma" giant GlaxoSmithKline (NYS: GSK) slightly disappointed its owners today, as its latest results revealed low growth in turnover and earnings. GSK's slow growthAs soon as GSK ...